Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers ; volume:4 ; number:1 ; day:22 ; month:12 ; year:2018 ; pages:1-9 ; date:12.2018
Cardio-Oncology ; 4, Heft 1 (22.12.2018), 1-9, 12.2018
- Urheber
-
Li, Vivian Wing-yi
Liu, Anthony Pak-yin
Ho, Karin Kar-Huen
Yau, Jeffrey Ping-Wa
Cheuk, Daniel Ka-leung
Cheung, Yiu-fai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-018-0035-0
- URN
-
urn:nbn:de:101:1-2019030110503400324652
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Vivian Wing-yi
- Liu, Anthony Pak-yin
- Ho, Karin Kar-Huen
- Yau, Jeffrey Ping-Wa
- Cheuk, Daniel Ka-leung
- Cheung, Yiu-fai
- SpringerLink (Online service)
Ähnliche Objekte (12)
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Risk of subsequent primary cancers in bladder cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Lifestyle among long-term survivors of cancers in young adulthood
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Risk of subsequent primary cancers in bladder cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Lifestyle among long-term survivors of cancers in young adulthood
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Risk of subsequent primary cancers in bladder cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment